Results 161 to 170 of about 303,882 (203)
Some of the next articles are maybe not open access.

[Endocrine ophthalmopathy].

Klinische Monatsblatter fur Augenheilkunde, 1985
The author lists the various ocular complications of Graves' disease, ranging from the very mild, which need no treatment, to those which require medical treatment, usually with cortisone, sometimes in combination with immunosuppressors. The relatively slight oculomotor problems can sometimes be alleviated with prisms.
openaire   +3 more sources

Ciamexon-treatment in endocrine ophthalmopathy

Acta Endocrinologica, 1987
In severe cases of e.o. IV to VI combined treatment with Cyclosporin A and corticosteroids is most effective whereas Ciamixon alone appears to be less effective. Patients who received Ciamexon some time after termination of Cyclosporin A treatment showed slight ophthalmological improvement or stabilization of the status (judged after short time of ...
C, Utech   +3 more
openaire   +2 more sources

Plasma exchange in endocrine ophthalmopathy

Journal of Clinical Apheresis, 1990
AbstractWe studied the effects of intensive plasma exchange on endocrine ophthalmopathy in 12 patients with Graves' disease and one with Hashimoto's thyroiditis. All patients were euthyroid at the time of plasma exchange. All but five had concomitant treatment with azathioprine.
G, Berlin   +3 more
openaire   +2 more sources

Endocrine ophthalmopathy and radioiodine therapy

Acta Oncologica, 2006
Endocrine ophthalmopathy is to some degree present in most patients with Graves' disease. In few cases, a severe form of the condition develops and in the majority of these cases, the course of the eye problems has been influenced by the treatment for thyrotoxicosis.
openaire   +2 more sources

In vitro synthesis of glycosaminoglycans in endocrine ophthalmopathy

Acta Endocrinologica, 1992
The effects of humoral and cell-mediated immunity on the glycosaminoglycan synthesis of retrobulbar fibroblasts was evaluated in patients with endocrine ophthalmopathy. After incubation with IgG and sera, secreted glycosaminoglycans, radiolabeled with D-6-3H-glucosamine and 35sulfate, were precipitated with cetylpyridinium chloride and ethanol ...
G, Kahaly, C, Stover, J, Beyer, E, Otto
openaire   +2 more sources

Graves' disease, endocrine ophthalmopathy and smoking

Acta Endocrinologica, 1993
We have evaluated the association between smoking, Graves' disease and endocrine ophthalmopathy in a case-control study of 208 patients with newly diagnosed Graves' disease and carried out a retrospective survey of 72 patients treated for Graves' disease and admitted to our ward because of endocrine ophthalmopathy.
B, Winsa, A, Mandahl, F A, Karlsson
openaire   +2 more sources

[The problems of endocrine ophthalmopathy].

Vestnik oftalmologii, 2008
Based on her own rich and many years' experience in following-up and treating patients with endocrine ophthalmopathy (EOP) and on the data available in the Russian and foreign literature, the author states the problems of EOP. These include the terminology and classification of a pathological process, a uniform treatment protocol by taking into account
openaire   +1 more source

Glucocorticoid-resistant forms of endocrine ophthalmopathy

Russian Annals of Ophthalmology
Endocrine ophthalmopathy (EO; also called Graves’ ophthalmopathy, thyroid eye disease) is a common extrathyroidal manifestation of Graves’ disease, characterized by the presence of autoimmune inflammatory process in the orbital soft tissues. The prevalence of EO is approximately 10 cases per 10.000 population, higher in individuals over 50 years old ...
openaire   +2 more sources

[Endocrine ophthalmopathy].

Fortschritte der Medizin, 1978
W, Wildmeister, E, Leicht, F A, Horster
openaire   +1 more source

Home - About - Disclaimer - Privacy